📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Diesse

1.1 - Company Overview

Diesse Logo

Diesse

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative in vitro diagnostic (IVD) systems for the diagnosis of infectious and autoimmune diseases; an Italian developer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Diesse

Elion Therapeutics Logo

Elion Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions focused on treating life-threatening IFIs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elion Therapeutics company profile →
TriPharm Logo

TriPharm

HQ: United States Website
  • Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TriPharm company profile →
Cempra Logo

Cempra

HQ: United States Website
  • Description: Provider of medicines for the treatment of bacterial infections and chronic illnesses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cempra company profile →
NovaDigm Therapeutics Logo

NovaDigm Therapeutics

HQ: United States Website
  • Description: Provider of vaccines that protect patients from contracting fungal and bacterial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NovaDigm Therapeutics company profile →
Eiger BioPharmaceuticals Logo

Eiger BioPharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies, including lonafarnib, an oral farnesyl-transferase inhibitor blocking Hepatitis Delta Virus replication; avexitide, a GLP-1 receptor antagonist for post-bariatric hypoglycemia and congenital hyperinsulinism; Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid Laminopathies; and an Expanded Access Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eiger BioPharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Diesse

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Diesse

2.2 - Growth funds investing in similar companies to Diesse

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Diesse

4.2 - Public trading comparable groups for Diesse

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Diesse

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Diesse

What does Diesse do?

Diesse is a provider of innovative in vitro diagnostic (IVD) systems for the diagnosis of infectious and autoimmune diseases; an Italian developer.

Who are Diesse's competitors?

Diesse's competitors and similar companies include Elion Therapeutics, TriPharm, Cempra, NovaDigm Therapeutics, and Eiger BioPharmaceuticals.

Where is Diesse headquartered?

Diesse is headquartered in Italy.

How many employees does Diesse have?

Diesse has 1,000 employees 🔒.

When was Diesse founded?

Diesse was founded in 2010 🔒.

What sector and industry vertical is Diesse in?

Diesse is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Diesse

Who are the top strategic acquirers in Diesse's sector and industry

Top strategic M&A buyers and acquirers in Diesse's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Diesse?

Top strategic M&A buyers groups and sectors for Diesse include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Diesse's sector and industry vertical

Which are the top PE firms investing in Diesse's sector and industry vertical?

Top PE firms investing in Diesse's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Diesse's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Diesse's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Diesse's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Diesse include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Diesse's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Diesse?

The key public trading comparables and valuation benchmarks for Diesse include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Diesse for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Diesse with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Diesse's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Diesse with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Diesse's' sector and industry vertical?

Access recent funding rounds and capital raises in Diesse's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Diesse